AdaptHealth Corp. Files 8-K with Regulatory Updates
Ticker: AHCO · Form: 8-K · Filed: Sep 30, 2024 · CIK: 1725255
Sentiment: neutral
Topics: 8-K, regulatory-disclosure, financial-statements
TL;DR
AdaptHealth filed an 8-K on Sep 30th for an event on Sep 24th, including financial statements.
AI Summary
AdaptHealth Corp. filed an 8-K on September 30, 2024, reporting an event on September 24, 2024. The filing is a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as DFB Healthcare Acquisitions Corp., is incorporated in Delaware and headquartered in Plymouth Meeting, PA.
Why It Matters
This 8-K filing indicates AdaptHealth Corp. is providing important regulatory disclosures and financial updates to the public, which could influence investor decisions.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting routine disclosures and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- AdaptHealth Corp. (company) — Registrant
- DFB Healthcare Acquisitions Corp. (company) — Former Company Name
- September 24, 2024 (date) — Earliest event date
- September 30, 2024 (date) — Filing date
- Plymouth Meeting, PA (location) — Principal executive offices
FAQ
What specific event occurred on September 24, 2024, that necessitated this 8-K filing?
The filing does not specify the exact event that occurred on September 24, 2024, but it is categorized under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
What is the primary business of AdaptHealth Corp.?
AdaptHealth Corp. operates in the 'SERVICES-HOME HEALTH CARE SERVICES' industry, with SIC code 8082.
When did AdaptHealth Corp. change its name from DFB Healthcare Acquisitions Corp.?
The date of the name change from DFB Healthcare Acquisitions Corp. to AdaptHealth Corp. was December 13, 2017.
Where are AdaptHealth Corp.'s principal executive offices located?
AdaptHealth Corp.'s principal executive offices are located at 220 West Germantown Pike, Suite 250, Plymouth Meeting, PA 19462.
What is the fiscal year end for AdaptHealth Corp.?
AdaptHealth Corp.'s fiscal year ends on December 31.
Filing Stats: 651 words · 3 min read · ~2 pages · Grade level 11.2 · Accepted 2024-09-30 16:15:09
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share AHCO The Nasdaq Stock Mar
Filing Documents
- tm2424628d1_8k.htm (8-K) — 28KB
- tm2424628d1_ex99-1.htm (EX-99.1) — 3KB
- 0001104659-24-104290.txt ( ) — 203KB
- ahco-20240924.xsd (EX-101.SCH) — 3KB
- ahco-20240924_lab.xml (EX-101.LAB) — 33KB
- ahco-20240924_pre.xml (EX-101.PRE) — 22KB
- tm2424628d1_8k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 24, 2024, AdaptHealth Corp. (the "Company") sent a notice (the "Notice of Expiration Date") to the holders of its outstanding private placement warrants issued pursuant to the Warrant Agreement, dated as of February 15, 2018 (the "Warrant Agreement"), by and among, the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent, (the "Private Placement Warrants"), confirming that the expiration date for the Private Placement Warrants is November 8, 2024, and that any Private Placement Warrants that are not exercised on or before November 8, 2024, (the "Expiration Date") shall become void, and all rights thereunder and all rights in respect thereof under the Warrant Agreement shall cease, at 5:00 p.m. New York City time on the Expiration Date. The Company had previously incorrectly reported in certain of its periodic filings that the Private Placement Warrants would expire on November 20, 2024, rather than the correct Expiration Date of November 8, 2024. The Notice of Expiration Date is furnished as Exhibit 99.1 hereto. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits 99.1 Notice of Expiration Date , dated as of September 24 , 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) - 2 - SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: September 30, 2024 AdaptHealth Corp. By: /s/ Jonathan B. Bush Name: Jonathan B. Bush Title: General Counsel - 3 -